4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-052262
Options or other derivatives
- CEO and CFO acquired 1,173,731 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Patel Snehal CEO and CFO | 2024-12-24 | Grant or award · Stock Options | +1,148,723 | 2,222,454 | D | ||
| Patel Snehal CEO and CFO | 2024-12-24 | Grant or award · Stock Options | +25,008 | 2,247,462 | I | ||
Loading xslF345X05/ownership.xml…